TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,031,874 | $6,258,000 | 6.29% |
| NEA Management Company, LLC | 2,086,755 | $6,427,000 | 0.32% |
| BVF INC/IL | 150,000 | $462,000 | 0.07% |
| Central Square Management LLC | 19,000 | $59,000 | 0.06% |
| ABNER HERRMAN & BROCK LLC | 20,000 | $62,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 137,000 | $422,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 31,000 | $95,000 | 0.01% |
| Spark Investment Management LLC | 11,100 | $34,000 | 0.01% |
| Waverly Advisors, LLC | 2,670 | $8,000 | 0.00% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 33,384 | $103,000 | 0.00% |